FBTAX
Price
$25.05
Change
-$0.02 (-0.08%)
Updated
May 22 closing price
Net Assets
1.37B
FHCCX
Price
$35.84
Change
-$0.27 (-0.75%)
Updated
May 22 closing price
Net Assets
3.57B
Interact to see
Advertisement

FBTAX vs FHCCX

Header iconFBTAX vs FHCCX Comparison
Open Charts FBTAX vs FHCCXBanner chart's image
Fidelity Advisor Biotechnology A
Price$25.05
Change-$0.02 (-0.08%)
VolumeN/A
Net Assets1.37B
Fidelity Advisor Health Care C
Price$35.84
Change-$0.27 (-0.75%)
VolumeN/A
Net Assets3.57B
FBTAX vs FHCCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTAX vs. FHCCX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and FHCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FHCCX has more cash in the bank: 3.57B vs. FBTAX (1.37B). FBTAX pays higher dividends than FHCCX: FBTAX (2.96) vs FHCCX (0.00). FBTAX was incepted earlier than FHCCX: FBTAX (24 years) vs FHCCX (28 years). FHCCX (1.69) is less costly to investors than FBTAX (0.96). FBTAX is a more actively managed with annual turnover of: 73.00 vs. FHCCX (37.00). FBTAX (0) and FHCCX (0) have matching initial minimum investment requirements. FBTAX annual gain was more profitable for investors over the last year : -10.54 vs. FHCCX (-20.88). FBTAX return over 5 years is better than : -14.23 vs. FHCCX (-20.50).
FBTAXFHCCXFBTAX / FHCCX
Total Expense Ratio0.961.6957%
Annual Report Gross Expense Ratio0.961.6957%
Fund Existence24 years28 years-
Gain YTD-7.865-7.363107%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B3.57B38%
Annual Yield % from dividends2.960.00-
Returns for 1 year-10.54-20.8850%
Returns for 3 years24.84-9.13-272%
Returns for 5 years-14.23-20.5069%
Returns for 10 years-10.67-1.71622%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGLAX14.21N/A
N/A
Brookfield Global Listed InfrastructureA
MSJCX16.19N/A
N/A
Morgan Stanley Global Endurance C
IYGIX39.25N/A
N/A
Macquarie Large Cap Growth Fund I
ERBIX18.49N/A
N/A
Eaton Vance RBA Equity Strategy Fd Cl I
JGISX82.47N/A
N/A
JPMorgan U.S. GARP Equity R6